🔎 Trials Near Me

Početna › Ulcerativni kolitis › Missouri › St. Louis

Kliničke studije za Ulcerativni kolitis u gradu St. Louis, MO

13 studija za Ulcerativni kolitis traži sudionike na lokacijama u gradu St. Louis i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

U tijeku regrutacijaFaza 2
  • Specialists In Gastroenterology /ID# 283939, St Louis
Od 18 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

U tijeku regrutacijaFaza 4
  • SSM Health Medical Group, Bridgeton · 15 mi udaljenosti
Od 18 do 80 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT06581328

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

U tijeku regrutacijaFaza 2
  • Site US-006, St Louis
Od 18 do 75 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT07845487

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

U tijeku regrutacijaFaza 2/3
  • Washington University, St Louis
Od 2 do 17 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT05076175

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

U tijeku regrutacijaFaza 3
  • Washington University School of Medicine, St Louis
Od 18 do 70 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06937086

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

U tijeku regrutacijaFaza 1
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • i još 1
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT03816345

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

U tijeku regrutacijaFaza 2
  • Center for Gastrointestinal Health - Fairview Heights, Belleville · 14 mi udaljenosti
Od 18 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07186101

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

U tijeku regrutacijaFaza 2
  • KAD Clinical Research, St Louis
Od 18 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07483073

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

U tijeku regrutacijaFaza 3
  • Washington University School of Medicine, St Louis
Od 2 do 19 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT04844606

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

U tijeku regrutacijaFaza 2
  • KAD Clinical Research, St Louis
  • Specialists in Gastroenterology, St Louis
Od 18 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07415044

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

U tijeku regrutacijaFaza 4
  • Washington University School of Medicine, St Louis
Od 18 do 65 godina · Oba spola · Ažurirano 21. ruj 2026. · NCT06095128

BOOM-IBD2 Pivotal Clinical Trial

U tijeku regrutacija
  • Gateway GI Research (Objective Health), St Louis
Od 18 do 85 godina · Oba spola · Ažurirano 6. kol 2026. · NCT06571669

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

U tijeku regrutacijaFaza 2
  • Mirador Therapeutics Selected Site, Bridgeton · 15 mi udaljenosti
Od 18 do 80 godina · Oba spola · Ažurirano 12. ožu 2026. · NCT07113522

Studije za Ulcerativni kolitis u drugim gradovima

Ostale studije u gradu St. Louis

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.